Pharmacological agents for reducing the haemodynamic response to tracheal intubation in paediatric patients: a

M Nazir1, B Salim1, F A Khan2

  • 1Senior Instructor, Anaesthesia, Aga Khan University, Karachi, Sindh, Pakistan.

Insights

Pharmacological agents, particularly opioids like fentanyl and remifentanil, can safely blunt the hemodynamic response to tracheal intubation in children. Careful dosing is recommended to avoid hypotension and monitor for rare side effects.

Area of Science:

  • Anesthesiology
  • Pediatric Critical Care
  • Pharmacology

Background:

  • Tracheal intubation can cause significant hemodynamic responses in pediatric patients.
  • Managing these responses is crucial for patient safety during surgery.
  • Pharmacological agents are often used to attenuate these effects.

Purpose of the Study:

  • To review the efficacy of pharmacological agents in blunting the hemodynamic response to tracheal intubation in pediatric patients.
  • To identify adverse effects associated with these agents.
  • To assess the role of these agents in reducing arrhythmias.

Main Methods:

  • Systematic literature search of PubMed, CINAHL, and Cochrane databases (1980-2014).
  • Inclusion of randomized controlled trials evaluating pharmacological agents' effects on hemodynamic response to intubation.
  • Outcome measures included blood pressure, heart rate, adverse effects, and arrhythmias.

Main Results:

  • Sixteen studies involving 1408 children were analyzed.
  • Opioids, including fentanyl, remifentanil, sufentanil, and alfentanil, demonstrated dose-dependent blunting of the hemodynamic response.
  • Higher doses of remifentanil and sufentanil were most effective but risked hypotension; side effects and arrhythmias were infrequent.

Conclusions:

  • Specific opioid doses (e.g., fentanyl 2 µg/kg, remifentanil 1 µg/kg) can safely attenuate the hemodynamic response to tracheal intubation in pediatric patients.
  • Close monitoring for rare side effects is advised when using these agents.
  • The identified safe and effective doses provide guidance for clinical practice.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
851
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.9K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622